| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
91,270,000 |
| Market
Cap: |
162.46(M) |
| Last
Volume: |
580,549 |
Avg
Vol: |
702,434 |
| 52
Week Range: |
$1.49 - $4.26 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Accuray is a radiation therapy company that develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments. Co.'s technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, its TomoTherapy platform, are designed to deliver various treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Co. also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
100,000 |
100,000 |
100,000 |
100,000 |
| Total Buy Value |
$156,045 |
$156,045 |
$156,045 |
$156,045 |
| Total People Bought |
1 |
1 |
1 |
1 |
| Total Buy Transactions |
2 |
2 |
2 |
2 |
| Total Shares Sold |
2,701 |
30,937 |
283,932 |
475,255 |
| Total Sell Value |
$4,597 |
$80,183 |
$717,312 |
$1,169,529 |
| Total People Sold |
1 |
3 |
7 |
8 |
| Total Sell Transactions |
1 |
4 |
18 |
36 |
| End Date |
2024-03-10 |
2023-12-08 |
2023-06-09 |
2022-06-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Nouri Alaleh |
SVP, General Counsel & |
• – – |
2015-03-31 |
4 |
D |
$9.30 |
$21,492 |
D/D |
(2,311) |
66,504 |
|
- |
|
| Levine Joshua |
President & CEO |
• – – |
2015-03-31 |
4 |
D |
$9.30 |
$60,478 |
D/D |
(6,503) |
829,050 |
|
- |
|
| Levine Joshua |
President & CEO |
• – – |
2015-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
835,553 |
|
- |
|
| Nouri Alaleh |
SVP, General Counsel & |
• – – |
2015-02-02 |
4 |
S |
$7.38 |
$30,487 |
D/D |
(4,131) |
68,815 |
|
- |
|
| Nouri Alaleh |
SVP, General Counsel & |
• – – |
2015-01-31 |
4 |
S |
$7.38 |
$7,624 |
D/D |
(1,033) |
72,946 |
|
- |
|
| Londy Kelly |
EVP Chief Commercial Officer |
• – – |
2015-01-02 |
4 |
D |
$7.21 |
$18,292 |
D/D |
(2,537) |
177,249 |
|
- |
|
| Levine Joshua |
President & CEO |
• – – |
2014-12-01 |
4 |
D |
$6.65 |
$173,499 |
D/D |
(26,090) |
785,553 |
|
- |
|
| Winger Dennis L |
Director |
– • – |
2014-12-01 |
4 |
D |
$6.65 |
$40,000 |
D/D |
(6,015) |
115,538 |
|
- |
|
| Weiss Robert S |
Director |
– • – |
2014-12-01 |
4 |
D |
$6.65 |
$40,000 |
D/D |
(6,015) |
195,538 |
|
- |
|
| Goldstein Jack |
Director |
– • – |
2014-12-01 |
4 |
D |
$6.65 |
$40,000 |
D/D |
(6,015) |
77,638 |
|
- |
|
| Pettingill Richard |
Director |
– • – |
2014-12-01 |
4 |
D |
$6.65 |
$40,000 |
D/D |
(6,015) |
55,341 |
|
- |
|
| Davila Elizabeth H |
Director |
– • – |
2014-12-01 |
4 |
D |
$6.65 |
$40,000 |
D/D |
(6,015) |
88,538 |
|
- |
|
| Londy Kelly |
EVP Chief Commercial Officer |
• – – |
2014-11-30 |
4 |
S |
$6.62 |
$15,047 |
D/D |
(2,273) |
179,786 |
|
- |
|
| Nouri Alaleh |
SVP, General Counsel & |
• – – |
2014-11-30 |
4 |
S |
$6.62 |
$1,774 |
D/D |
(268) |
73,979 |
|
- |
|
| Rizk Emad T. |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
49,694 |
|
- |
|
| Lavigne Louis J Jr |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
121,452 |
|
- |
|
| Winger Dennis L |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
121,553 |
|
- |
|
| Weiss Robert S |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
201,553 |
|
- |
|
| Goldstein Jack |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
83,653 |
|
- |
|
| Pettingill Richard |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
61,356 |
|
- |
|
| Davila Elizabeth H |
Director |
– • – |
2014-11-28 |
4 |
A |
$0.00 |
$0 |
D/D |
17,416 |
94,553 |
|
- |
|
| Levine Joshua |
President & CEO |
• – – |
2014-11-03 |
4 |
B |
$6.34 |
$634,000 |
D/D |
100,000 |
811,643 |
2.74 |
- |
|
| Nouri Alaleh |
SVP, General Counsel & |
• – – |
2014-10-31 |
4 |
D |
$6.33 |
$11,426 |
D/D |
(1,805) |
74,247 |
|
- |
|
| Londy Kelly |
EVP Chief Commercial Officer |
• – – |
2014-10-31 |
4 |
D |
$6.33 |
$11,654 |
D/D |
(1,841) |
182,059 |
|
- |
|
| Londy Kelly |
EVP Chief Commercial Officer |
• – – |
2014-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
62,009 |
183,900 |
|
- |
|
839 Records found
|
|
Page 15 of 34 |
|
|
